Cabot (NYSE:CBT) Rating Lowered to Hold at Wall Street Zen

Cabot (NYSE:CBT) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday, Wall Street Zen reports.

CBT has been the subject of several other research reports. UBS Group lowered their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday, August 5th. Truist Financial set a $100.00 price objective on shares of Cabot in a report on Wednesday, August 5th. Mizuho lifted their price objective on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. Finally, JPMorgan Chase & Co. increased their target price on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $89.00.

Cabot Trading Up 0.2%

CBT opened at $77.14 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The stock has a market capitalization of $3.98 billion, a price-to-earnings ratio of 21.73, a PEG ratio of 9.06 and a beta of 0.83. The business has a fifty day moving average price of $82.83 and a 200 day moving average price of $82.22. Cabot has a 12 month low of $58.33 and a 12 month high of $94.53.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The business had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. During the same period in the previous year, the company posted $1.90 earnings per share. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts expect that Cabot will post 6.35 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Sean Keohane sold 134,895 shares of the company’s stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold 229,597 shares of company stock valued at $19,646,746 in the last quarter. Insiders own 3.08% of the company’s stock.

Institutional Investors Weigh In On Cabot

Several hedge funds have recently made changes to their positions in the business. BlackRock Inc. acquired a new position in Cabot in the 2nd quarter valued at about $633,302,000. State Street Corp grew its stake in shares of Cabot by 6.8% in the 2nd quarter. State Street Corp now owns 2,165,434 shares of the specialty chemicals company’s stock valued at $196,665,000 after purchasing an additional 138,098 shares during the last quarter. Bank of America Corp DE purchased a new position in shares of Cabot in the 2nd quarter valued at approximately $150,772,000. Dimensional Fund Advisors LP increased its holdings in shares of Cabot by 4.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock valued at $131,253,000 after purchasing an additional 79,499 shares during the period. Finally, Sei Investments Co. increased its holdings in shares of Cabot by 6.5% in the first quarter. Sei Investments Co. now owns 1,051,578 shares of the specialty chemicals company’s stock valued at $79,194,000 after purchasing an additional 64,122 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company develops and manufactures materials used by industrial and consumer-product manufacturers worldwide.

Cabot’s products include reinforcing carbon blacks used in tires, automotive components, and other rubber products; specialty carbon blacks used in coatings, plastics, inks, and batteries; and fumed silica used in adhesives, sealants, coatings, and personal-care applications.